Skip to content
Disclosery

EXANE DERIVATIVES: OKTA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on OKTA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 15 OKTA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 15 shares
    Change vs previous 13F -720 shares

    <0.01% of the 13F portfolio, value $1,356.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 735 shares
    Change vs previous 13F -108 shares

    0.03% of the 13F portfolio, value $110,949.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 843 shares
    Change vs previous 13F -239 shares

    0.05% of the 13F portfolio, value $188,968.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 1,082 shares
    Change vs previous 13F -209 shares

    0.06% of the 13F portfolio, value $256,793.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 1,291 shares
    Change vs previous 13F +36 shares

    0.08% of the 13F portfolio, value $321,568.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,255 shares
    Change vs previous 13F +655 shares

    0.08% of the 13F portfolio, value $276,627.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 600 shares
    Change vs previous 13F not available

    0.05% of the 13F portfolio, value $152,549.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).